<DOC>
	<DOCNO>NCT00444340</DOCNO>
	<brief_summary>This study extension trial 0881A3-312-EU design provide information safety efficacy etanercept patient ankylose spondylitis 3 additional year .</brief_summary>
	<brief_title>An Open-Label Multicentre Long-Term Extension Study Etanercept Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Completed study 0881A3312EU Agreeable utilize medically acceptable form contraception Able reconstitute selfinject designee Withdrawn study 0881A3312EU Abnormal hematology chemistry profile Clinically relevant medical condition include : congestive heart failure , multiple sclerosis central demyelinating disease , blood dyscrasia , cancer serious infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>